Target intelligence / Profile preview

Novel ankyrin repeat domain 20 family member pseudogene (ENSG00000288694)

Target
ENSG00000288694
Molecular classification
Other, Pseudogene
01

Overview

The "novel ankyrin repeat domain 20 family member pseudogene" (ENSG00000288694) is annotated as a human pseudogene and is not believed to produce a functional protein product. While its designation refers to homology with the ankyrin repeat domain 20 family, this locus is non-coding and does not participate in known biological or pathological processes. It is not considered a therapeutic target in drug discovery or pharmacology, and no genetic or functional associations relevant to human disease, biomarkers, drug action, or safety have been described in the literature or curated databases as of the present date. This "target" is a pseudogene: an inactive genomic locus resembling a member of the ankyrin repeat domain family, with no evidence for a role as a functional protein or drug target. Using this as a candidate for therapeutic targeting, biomarker development, or mechanism studies is unsupported by the current evidence.

02

Mechanism of action

None applicable.

Beyond the preview

Go deeper on Novel ankyrin repeat domain 20 family member pseudogene (ENSG00000288694).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel ankyrin repeat domain 20 family member pseudogene (ENSG00000288694).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call